A selection of some of the most poignant words spoken by interviewees this year

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

A quick look at trends in single use – plus top tips from Avantor for making the switch.

Ali Pashazadeh from Treehill Partners offers his advice for navigating the turbulent period and keeping on track for commercial success.

Academia suggests we need to upgrade lyophilization, but scientists are being slow to respond

Why virtual reality represents the new standard for healthcare and pharma manufacturing training

Gene therapy has the potential to transform lives, but promising treatments for a wide range of diseases require optimal cell culture media solutions

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.